| Catalog Number |
383518 |
| Medical Device Problem Code |
Leak/Splash (1354)
|
| Health Effect - Clinical Code |
Overdose (1988)
|
| Date of Event |
10/11/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that the bd nexiva¿ closed iv catheter system tubing "blew" during use and contrast leaked from it.As a result, the ct scan was not completed and the patient did not receive the full ct contrast dose.A new iv was placed, but a repeat ct scan was "not needed".The following information was provided by the initial reporter: "iv tubing blew and contrast leaked.The rate and contrast used were within the manufacturer's guideline.(isovue 300; 5.5 ml/sec)" "ct scan was incomplete due to the contrast leak.Pt.Did not receive full ct contrast dose.New iv placed.A repeat ct scan was not needed.".
|
| |
|
Additional Manufacturer Narrative
|
|
H.6.Investigation summary: there was no sample or photo available to bd for evaluation.Therefore, bd was unable to perform a thorough investigation to verify the reported issue.Since, an investigation could not be performed bd was unable to determine a possible root cause.The manufacturing facility has been notified of this event but without a sample no corrective actions could be identified.A review of the device history record was performed and no quality issues were found during production.H3 other text : see section h.10.
|
| |
|
Event or Problem Description
|
|
It was reported that the bd nexiva¿ closed iv catheter system tubing "blew" during use and contrast leaked from it.As a result, the ct scan was not completed and the patient did not receive the full ct contrast dose.A new iv was placed, but a repeat ct scan was "not needed".The following information was provided by the initial reporter: "iv tubing blew and contrast leaked.The rate and contrast used were within the manufacturer's guideline.(isovue 300; 5.5 ml/sec)".
|
| |
|
Search Alerts/Recalls
|